BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25705800)

  • 21. Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial.
    Arabi YM; Aljumah A; Dabbagh O; Tamim HM; Rishu AH; Al-Abdulkareem A; Knawy BA; Hajeer AH; Tamimi W; Cherfan A
    CMAJ; 2010 Dec; 182(18):1971-7. PubMed ID: 21059778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mild cognitive deficits in patients with primary adrenal insufficiency.
    Tiemensma J; Andela CD; Biermasz NR; Romijn JA; Pereira AM
    Psychoneuroendocrinology; 2016 Jan; 63():170-7. PubMed ID: 26454105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual-release hydrocortisone and its benefits on cognitive function and quality of sleep.
    Krekeler C; Kropp P; Blacha AK; Rahvar AH; Harbeck B
    Endocrine; 2021 Apr; 72(1):223-233. PubMed ID: 33625720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hair cortisol content in patients with adrenal insufficiency on hydrocortisone replacement therapy.
    Gow R; Koren G; Rieder M; Van Uum S
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):687-93. PubMed ID: 21521272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
    Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic evidence for suboptimal treatment of adrenal insufficiency with currently available hydrocortisone tablets.
    Simon N; Castinetti F; Ouliac F; Lesavre N; Brue T; Oliver C
    Clin Pharmacokinet; 2010 Jul; 49(7):455-63. PubMed ID: 20528006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perioperative glucocorticoid prescribing habits in patients with inflammatory bowel disease: a call for standardization.
    Lamore RF; Hechenbleikner EM; Ha C; Salvatori R; Harris LH; Marohn MR; Gearhart SL; Efron JE; Wick EC
    JAMA Surg; 2014 May; 149(5):459-66. PubMed ID: 24647868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of Adrenal Crisis: Cortisol Responses to Major Stress Compared to Stress Dose Hydrocortisone Delivery.
    Prete A; Taylor AE; Bancos I; Smith DJ; Foster MA; Kohler S; Fazal-Sanderson V; Komninos J; O'Neil DM; Vassiliadi DA; Mowatt CJ; Mihai R; Fallowfield JL; Annane D; Lord JM; Keevil BG; Wass JAH; Karavitaki N; Arlt W
    J Clin Endocrinol Metab; 2020 Jul; 105(7):2262-74. PubMed ID: 32170323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher hydrocortisone dose increases bilirubin in hypopituitary patients- results from an RCT.
    Werumeus Buning J; Kootstra-Ros JE; Brummelman P; van den Berg G; van der Klauw M; Wolffenbuttel BH; van Beek AP; Dullaart RP
    Eur J Clin Invest; 2016 May; 46(5):475-80. PubMed ID: 26999644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Switching From Immediate-Release to Fractionated Dual-Release Hydrocortisone May Improve Metabolic Control and QoL in Selected Primary Adrenal Insufficiency Patients.
    Delle Cese F; Corsello A; Cintoni M; Locantore P; Pontecorvi A; Corsello SM; Paragliola RM
    Front Endocrinol (Lausanne); 2020; 11():610904. PubMed ID: 33597926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive effects of intravenous hydrocortisone in subjects with PTSD and healthy control subjects.
    Grossman R; Yehuda R; Golier J; McEwen B; Harvey P; Maria NS
    Ann N Y Acad Sci; 2006 Jul; 1071():410-21. PubMed ID: 16891588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers.
    Jung C; Greco S; Nguyen HH; Ho JT; Lewis JG; Torpy DJ; Inder WJ
    BMC Endocr Disord; 2014 Nov; 14():91. PubMed ID: 25425285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of epidural methylprednisolone acetate injection on the hypothalamic-pituitary-adrenal axis.
    Habib G; Jabbour A; Salman J; Hakim G; Haddad H
    J Clin Anesth; 2013 Dec; 25(8):629-33. PubMed ID: 23988802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immediate versus modified release hydrocortisone in mitotane-treated patients with adrenocortical cancer.
    Weigel M; Hahner S; Sherlock M; Agha A; Behan LA; Stewart PM; Arlt W; Beier D; Frey K; Zopf K; Quinkler M
    Clin Endocrinol (Oxf); 2017 Apr; 86(4):499-505. PubMed ID: 28063163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydrocortisone accelerates the decay of iconic memory traces: on the modulation of executive and stimulus-driven constituents of sensory information maintenance.
    Miller R; Weckesser LJ; Smolka MN; Kirschbaum C; Plessow F
    Psychoneuroendocrinology; 2015 Mar; 53():148-58. PubMed ID: 25618593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute glucocorticoid effects on the multicomponent model of working memory.
    Vaz LJ; Pradella-Hallinan M; Bueno OF; Pompéia S
    Hum Psychopharmacol; 2011 Oct; 26(7):477-87. PubMed ID: 21953602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early Metabolic Benefits of Switching Hydrocortisone to Modified Release Hydrocortisone in Adult Adrenal Insufficiency.
    Bannon CAM; Border D; Hanson P; Hattersley J; Weickert MO; Grossman A; Randeva HS; Barber TM
    Front Endocrinol (Lausanne); 2021; 12():641247. PubMed ID: 33776936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial.
    Asehnoune K; Seguin P; Allary J; Feuillet F; Lasocki S; Cook F; Floch H; Chabanne R; Geeraerts T; Roger C; Perrigault PF; Hanouz JL; Lukaszewicz AC; Biais M; Boucheix P; Dahyot-Fizelier C; Capdevila X; Mahe PJ; Le Maguet P; Paugam-Burtz C; Gergaud S; Plaud B; Constantin JM; Malledant Y; Flet L; Sebille V; Roquilly A;
    Lancet Respir Med; 2014 Sep; 2(9):706-16. PubMed ID: 25066331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma.
    Zueger T; Kirchner P; Herren C; Fischli S; Zwahlen M; Christ E; Stettler C
    J Clin Endocrinol Metab; 2012 Oct; 97(10):E1938-42. PubMed ID: 22872686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency.
    Nilsson AG; Marelli C; Fitts D; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Olsson T; Ragnarsson O; Ryberg M; Wahlberg J; Lennernäs H; Skrtic S; Johannsson G
    Eur J Endocrinol; 2014 Sep; 171(3):369-77. PubMed ID: 24944332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.